Related Experiment Video
Updated: May 3, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
[Intravitreal bevacizumab for choroidal neovascularization associated with Best's disease]
D Velazquez-Villoria1, C Macià Badia1, J Rigo Quera1
1Servicio de Oftalmología, Hospital Vall d'Hebrón, Barcelona, España.
Case Report:
A 27-year old woman presented with loss of vision in the right eye (20/200). Ophthalmoscopic examination showed intrarretinal hemorrhage in the macular region with neurosensory detachment in the right eye, and viteliform deposit on the left eye. Fluorescein angiography and the electrooculogram confirmed the diagnosis of choroidal neovascularization associated with Best's disease. Four weeks after a single bevacizumab intravitreal injection, visual acuity was restored (20/25) and remained stable after a 12 month follow-up.
Discussion:
Intravitreal bevacizumab appears to be an effective treatment for choroidal neovascularization associated to Best's disease.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy
Glaucoma: Overview

